Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01688843 · ClinicalTrials.gov registry record · NA
Safety and Performance Study of the INGEVITY Lead
A NA study, sponsored by Boston Scientific Corporation.
- Completed
- Registry status
- NA
- Development phase
- 1,060
- Enrollment target
NCT01688843 is a NA study that has completed, run by Boston Scientific Corporation. The registered enrollment target is 1,060 participants.
The verdict
NCT01688843, a NA study, has completed, sponsored by Boston Scientific Corporation.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,060 participants
- Enrollment target
Study Summary
The objective of this study is to gather data to establish the safety, performance and effectiveness of the INGEVITY pace/ sense leads.
Interventions
- DEVICE INGEVITY lead
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,060 participants |
| Start Date | 2012-10 |
| Est. Completion | 2019-02 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01688843
The ClinicalTrials.gov registry entry for NCT01688843 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 1,060 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Boston Scientific Corporation, which has 280 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which INGEVITY lead is the first listed.
NCT01688843 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01688843 about?
NCT01688843 is a clinical study titled "Safety and Performance Study of the INGEVITY Lead". The objective of this study is to gather data to establish the safety, performance and effectiveness of the INGEVITY pace/ sense leads.
What is the current status of trial NCT01688843?
This trial is currently completed. It is a NA study. The enrollment target is 1,060 participants. The study started on 2012-10. Estimated completion is 2019-02.
What interventions are being tested in trial NCT01688843?
The interventions under investigation include: INGEVITY lead (DEVICE).
Who is sponsoring clinical trial NCT01688843?
This trial is sponsored by Boston Scientific Corporation, which has 280 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.